Login
Companies $VNRX
$0.19 -$0.01 (2.8%) After hours
VOLITIONRX LTD logo

VOLITIONRX LTD

volition.com

What Do They Do?

Develops blood tests that use chromosome-based markers to detect and monitor cancers and other diseases for human healthcare and veterinary use.

How Do They Make Money?

Customers buy Nu.Q® Vet cancer tests, nucleosomes and research-use kits; Volition also earns money from laboratory work for third parties and licensing rights. Product sales are paid when goods ship, while lab and licensing revenue comes from services and rights provided under agreements.

FY2025 revenue

Who Are Their Customers?

Veterinarians can obtain the dog cancer test through distributors, including Antech Diagnostics, IDEXX Laboratories and Fujifilm Vet Systems. Drug developers and scientists use Nu.Q® Discover assays and related research tools.

Do Revenues Turn Into Profits?

No. It lost $23.4M in FY2025.

Operating income, FY2025
−1258% of revenue
▲ +20% (Loss) vs FY2024 (−$27M, −2191%)
Net income, FY2025
−1352% of revenue
▲ +13% (Loss) vs FY2024 (−$27M, −2186%)
Free cash flow, FY2025
−1145% of revenue
▲ +24% (Loss) vs FY2024 (−$26.2M, −2122%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ +157%
vs $627.3K in Q3 FY2025
Net income
▲ +29% (Loss)
vs −$5.4M in Q3 FY2025
  • Nov 12, 2026 Volition reported third-quarter results and business updates The update described a French government-funded sepsis evaluation, licensing discussions for Capture-Seq and an expected French reimbursement submission for its lung cancer test.

Growing. Revenue grew 19.2x in 4 years, from $90K in FY2021 to $1.7M in FY2025, about 109% a year.

Who Do They Compete With?

Competes with Exact Sciences, Guardant Health, GRAIL, Natera, Caris Life Sciences, Freenome Holdings, CellMax Life, Archer DX, Foundation Medicine, Oncocyte, OpKo Health, MDNA Life Sciences, Abbott Laboratories, Cepheid, Hologic, Agilent Technologies, Qiagen, Thermo Fisher, Illumina, and Becton Dickinson

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support